PASITHEA THERAPEUTICS CORP. (KTTAW) Free cash flow 2021–2023
PASITHEA THERAPEUTICS CORP. (KTTAW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$12.8MFY2023 · since FY2021: -$3.2M → -$12.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$12.8M | +12.4% |
| FY2022 | -$14.7M | -359.0% |
| FY2021 | -$3.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice